Competences
Competences

Licensing

Case study

Description

  • Leading generic company failed in a very late stage in the development in an important molecule
  • Searched for the quickest possible solution

Achievements

  • Found and persuaded a European company to perform an MRP into Spain of that product
  • Support in the MRP management
  • Support in a big crisis with the Spanish authorities in the Day 88 of the MRP

Economic Impact

  • Launch of that molecule prevented the company of not complying to a big part of the budget for that molecule

GALENICUM is currently following a twofold strategy regarding in-licensing needs of the Laboratories

  • Selling and management of National submissions and MRP procedures of companies represented by Galenicum
  • Broad respiratory portfolio (i.e. Salbutamol, other combination inhalers, etc) Oncology Portfolio both in solids and injectables
  • Hormone and steroid
  • Partnership alliances for development of new products, from pharmaceutical development up to submission stage

The combination of the products available from our partners combined with the products that result from alliances lets us cover most of the products needed today by the companies

Own development

  • Galenicum has concluded already two developments of 2 of the biggest blockbusters. If you want more information please contact us
  • We are engaged in three generic developments currently
Back to Competences Back to Competences